Investing
Morning Analyst Calls Briefing for Friday, November 18, 2022
Published:
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Domino’s Pizza (DPZ) upgraded to Buy from Neutral at Northcoast; tgt $460
> Pinnacle West (PNW) upgraded to Neutral from Sell at Guggenheim; tgt raised to $70
> Ross Stores (ROST) upgraded to Buy from Hold at Gordon Haskett; tgt $130
Downgrades:
> Chart Industries (GTLS) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $133
> Editas Medicine (EDIT) downgraded to Neutral from Outperform at Credit Suisse; tgt lowered to $13
> Editas Medicine (EDIT) downgraded to Perform from Outperform at Oppenheimer; tgt lowered to $12
> HP Inc. (HPQ) downgraded to Neutral from Outperform at Credit Suisse
> RH (RH) downgraded to Neutral from Outperform at Wedbush; tgt lowered to $270
Others:
> 4D Molecular Therapeutics (FDMT) initiated with a Buy at H.C. Wainwright; tgt $36
> Akili Inc. (AKLI) initiated with a Neutral at BofA Securities; tgt $2
> Amgen (AMGN) initiated with an Underperform at Credit Suisse; tgt $240
> Arcus Biosciences (RCUS) initiated with a Neutral at BofA Securities; tgt $33
> Bristol-Myers (BMY) initiated with a Neutral at Credit Suisse; tgt $78
> Conagra (CAG) upgraded to Buy from Neutral at UBS; tgt raised to $41
> CoStar Group (CSGP) resumed with a Buy at BofA Securities; tgt $100
> DraftKings (DKNG) initiated with an Overweight at Piper Sandler; tgt $21
> Dragonfly Energy (DFLI) initiated with a Buy at Chardan Capital Markets; tgt $15
> Eli Lilly (LLY) initiated with an Outperform at Credit Suisse; tgt $395
> Fulgent Genetics (FLGT) initiated with an Outperform at Raymond James; tgt $45
> Insmed (INSM) initiated with a Buy at BofA Securities; tgt $39
> Johnson & Johnson (JNJ) initiated with a Neutral at Credit Suisse; tgt $170
> Merck (MRK) initiated with an Outperform at Credit Suisse; tgt $120
> NeoGames (NGMS) initiated with an Underperform at BofA Securities; tgt $16
> Pfizer (PFE) initiated with an Outperform at Credit Suisse; tgt $55
> Precigen (PGEN) initiated with an Overweight at Cantor Fitzgerald; tgt $7
Research calls posted earlier this morning are available here.
Is Your Money Earning the Best Possible Rate? (Sponsor)
Let’s face it: If your money is just sitting in a checking account, you’re losing value every single day. With most checking accounts offering little to no interest, the cash you worked so hard to save is gradually being eroded by inflation.
However, by moving that money into a high-yield savings account, you can put your cash to work, growing steadily with little to no effort on your part. In just a few clicks, you can set up a high-yield savings account and start earning interest immediately.
There are plenty of reputable banks and online platforms that offer competitive rates, and many of them come with zero fees and no minimum balance requirements. Click here to see if you’re earning the best possible rate on your money!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
